1Rahman I , Swarska E, Henry M, et al. Is there any relationship between plasma antioxidant capacity and lung function in smokers and in patients with COPD? Thorax, 2000 ; 55 : 189.
2Manee W. Oxidants/antioxidants and COPD. Chest, 2000;117:303.
3Lothian B, Grey V, John R. Treatment of obstructive airway disease with a cysteine donor protein supplenment. Chest, 2000 ;117:914.
4Cooper JD, Trulack EP, Triantafillow AN, et al. Bilaterla pneumonectony (volume reduction) for chronic obstructive pulmonary disease. Thorac Cardiovasc Surg. 1995 ; 1 - 09 : 106.
5Yusen KD, Lefrak SS, Evaluation of patients with emphysema for lung volume reduction surgery. Semi Thorac Cardiovasc Surg. 1996 ; 8 : 83.
6Mckenna RJ, Brenner M, Fischel RJ, et al. Patient selection criteria for lung volume reduction surgery. Thorac Cardiovasc Surg, 1997 ; 114 : 956.
7Schols AM, Soeters B, Mostert R, et al. Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease A placebo - controlled rarrlomized trial. Am J respir Crit Care Med, 1995;152:1268.
8Gregory SP. The effect of growth hormone on weight gain and pulmonary function in patients with chronic obstructive lung disease . Chest, 1991 ; 99 : 1449.
9Marehesani F, Valerio G, Dardes N, et al. Effect of intravenous fructose 1, 6 - diphosphate administration in malnourished COPD patient with chronic espiratory failure. Respiration,2000;67(2):177.
10Ferreira IM, Verreschi IT, Nery LE, et al. The influence of 6 months of oral anabolie steroids on body mass and respiratory museles in under nourished COPD patients. Chest, 1998; 114(1):19.
